Biologic Drugs With Mechanism of Action: Tumor Necrosis Factor Receptor Blocking Activity
✉ Email this page to a colleague
Biologic Drugs With Mechanism of Action: Tumor Necrosis Factor Receptor Blocking Activity
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 1998-08-24 | ⤷ Subscribe | ⤷ Subscribe |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 1998-11-02 | ⤷ Subscribe | ⤷ Subscribe |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 1998-11-02 | ⤷ Subscribe | ⤷ Subscribe |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 1998-11-02 | ⤷ Subscribe | ⤷ Subscribe |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 1998-11-02 | ⤷ Subscribe | ⤷ Subscribe |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 1998-11-02 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |